This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in 2014, its patent protection will begin expiring in 2028. This will allow …
Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
view original post